On the other hand, the positive association between adiponectin and HCC risk is surprising and needs further investigations, given that adiponectin was reported to be protective against fatty liver disease and a low circulating adiponectin has been observed in patients with chronic hepatitis and hepatic steatosis.42, 43. The gene discussed is ADIPOQ; the disease is hepatocellular carcinoma.